(LGND) Ligand Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Ligand Pharmaceuticals | (LGND) share price targets
Complete technical analysis of Ligand Pharmaceuticals (LGND) by charts plus indicators, forecast predictions and share price targets for Ligand Pharmaceuticals (LGND)
Ligand Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-06-18 View latest technical analysis
10 day averaged volume of Ligand Pharmaceuticals is 100010
Date | Daily Closing Price | Open | High | Low | Volume |
18 Tue Jun 2024 | 80.54 | 80.27 | 81.29 | 79.50 | 0.922 times |
18 Tue Jun 2024 | 80.54 | 80.27 | 81.29 | 79.50 | 0.922 times |
17 Mon Jun 2024 | 80.64 | 80.00 | 80.75 | 77.58 | 0.948 times |
14 Fri Jun 2024 | 80.06 | 81.04 | 81.23 | 78.81 | 0.851 times |
13 Thu Jun 2024 | 81.34 | 80.17 | 81.52 | 78.91 | 0.718 times |
12 Wed Jun 2024 | 80.15 | 80.59 | 81.89 | 80.15 | 0.806 times |
11 Tue Jun 2024 | 80.10 | 78.85 | 80.42 | 77.51 | 1.141 times |
10 Mon Jun 2024 | 79.53 | 80.61 | 80.61 | 77.43 | 1.368 times |
07 Fri Jun 2024 | 81.36 | 81.38 | 82.20 | 79.69 | 1.424 times |
06 Thu Jun 2024 | 82.37 | 83.41 | 83.41 | 81.49 | 0.965 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 80.2 as stoploss in an intra day buy trade for a target of 82.91. However, stock will show a bearish move below 80.2.
Share price targets for Ligand Pharmaceuticals (LGND)
Target Type | Value |
Downside Target | 67.72 |
Downside Target | 77.43 |
Downside Target | 79.50 |
Upside Target | 81.73 |
Upside Target | 81.89 |
Upside Target | 83.09 |
Upside Target | 86.86 |
Upside Target | 88.52 |
Upside Target | 88.73 |
Upside Target | 94.57 |
Intraday share price targets for Ligand Pharmaceuticals (LGND)
Target Type | Value |
Downside Intraday Target | 79.6 |
Downside Intraday Target | 78.65 |
Upside Intraday Target | 81.39 |
Upside Intraday Target | 82.23 |
Downside Intraday Target | 80.44 |
Weekly technical analysis of Ligand Pharmaceuticals (LGND)
Date | Weekly Closing Price | Open | High | Low | Volume |
18 Tue Jun 2024 | 80.54 | 80.27 | 81.29 | 79.50 | 0.493 times |
18 Tue Jun 2024 | 80.54 | 80.00 | 81.29 | 77.58 | 0.383 times |
14 Fri Jun 2024 | 80.06 | 80.61 | 81.89 | 77.43 | 0.744 times |
07 Fri Jun 2024 | 81.36 | 85.44 | 88.73 | 79.50 | 1.34 times |
31 Fri May 2024 | 85.05 | 86.40 | 86.86 | 83.09 | 0.953 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Ligand Pharmaceuticals (LGND)
Date | Monthly Closing Price | Open | High | Low | Volume |
18 Tue Jun 2024 | 80.54 | 85.44 | 88.73 | 77.43 | 0.442 times |
31 Fri May 2024 | 85.05 | 70.12 | 88.52 | 69.51 | 0.924 times |
30 Tue Apr 2024 | 69.89 | 73.35 | 81.73 | 67.72 | 0.871 times |
28 Thu Mar 2024 | 73.10 | 80.05 | 80.94 | 68.25 | 1.141 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Ligand Pharmaceuticals (LGND)
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Ligand Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Ligand Pharmaceuticals in short term but the sell signal is initial and weak.
Ligand Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Ligand Pharmaceuticals in short term
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Ligand Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 80.64 and Ligand Pharmaceuticals (LGND) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Ligand Pharmaceuticals (LGND) stock. Volume based technical analysis of Ligand Pharmaceuticals (LGND) stock is negative.
Ligand Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Ligand Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Ligand Pharmaceuticals in short term but the sell signal is initial and weak.
Ligand Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Ligand Pharmaceuticals in short term
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Ligand Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 80.64 and Ligand Pharmaceuticals (LGND) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Ligand Pharmaceuticals (LGND) stock. Volume based technical analysis of Ligand Pharmaceuticals (LGND) stock is negative.
Ligand Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.